|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Aarhus University Hospital DanORC Nordic Centre of Excellence Arla amba, Denmark |
|---|---|
| Information provided by: | Aarhus University Hospital |
| ClinicalTrials.gov Identifier: | NCT00809874 |
Purpose
The purpose of this study is to determine the effects of dietary protein on blood lipids and gut hormones after a fat-rich meal.
Hypothesis: Certain dietary proteins reduce the amount of fat circulating in the blood stream following a fat rich meal. The effect is dependant of both the quality and the quantity of protein ingested.
| Condition | Intervention |
|---|---|
|
Postprandial Lipaemia Postprandial Incretins Postprandial Inflammation |
Dietary Supplement: Casein Dietary Supplement: Whey Isolate Dietary Supplement: Whey Hydrolysate Dietary Supplement: Alphalact-Albumin |
| Study Type: | Interventional |
| Study Design: | Prevention, Randomized, Open Label, Uncontrolled, Crossover Assignment, Efficacy Study |
| Official Title: | Effects of Dietary Proteins on Postprandial Lipaemia and Incretin Responses in Obese Subjects |
| Enrollment: | 11 |
| Study Start Date: | February 2008 |
| Study Completion Date: | December 2008 |
| Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Casein: Active Comparator | Dietary Supplement: Casein |
| Whey Isolate: Active Comparator | Dietary Supplement: Whey Isolate |
| Whey Hydrolysate: Active Comparator | Dietary Supplement: Whey Hydrolysate |
| Alphalact-Albumin: Active Comparator | Dietary Supplement: Alphalact-Albumin |
Eligibility| Ages Eligible for Study: | 40 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Denmark, - | |
| Department of Clinical Nutrion | |
| Aarhus, -, Denmark, 8000 | |
| Principal Investigator: | K Hermansen, Professor, MD | Department of Endocrinology and Metabolism, Aarhus University Hospital |
More Information
| Responsible Party: | Department of Endocrinology And Metabolism, Aarhus University Hospital ( Kjeld Hermansen, Professor, Chief Physician, MD, Dr.Med.Sci ) |
| Study ID Numbers: | CERN-PPL-JHJ |
| Study First Received: | December 16, 2008 |
| Last Updated: | March 17, 2009 |
| ClinicalTrials.gov Identifier: | NCT00809874 History of Changes |
| Health Authority: | Denmark: Ethics Committee |
|
Postprandial Period Postprandial Lipaemia Incretins Subclinical Inflammation |
Obesity Atherosclerosis Triglyceride Lipoproteins |
|
Atherosclerosis Obesity Hyperlipidemias Metabolic Diseases Hormone Antagonists Hormones, Hormone Substitutes, and Hormone Antagonists Hormones |
Inflammation Caseins Incretins Metabolic Disorder Dyslipidemias Lipid Metabolism Disorders |
|
Pathologic Processes Metabolic Diseases Hyperlipidemias Physiological Effects of Drugs Hormones, Hormone Substitutes, and Hormone Antagonists Incretins |
Hormones Pharmacologic Actions Dyslipidemias Lipid Metabolism Disorders Inflammation |
